论文部分内容阅读
本文对５２例急性心肌梗塞（ＡＭＩ）６小时内入院患者进行静脉给药溶解血栓治疗，其溶栓药物为尿激酶（ＵＫ）、去纤酶，其中６例并用前列腺素Ｅ１（ＰＧＥ１）联合溶栓。其结果显示：５２例中再通２９例再通率５５．７７％。其中ＵＫ组３６例再通２０例，再通率５５．５６％；ＵＫ＋ＰＧＥ１组６例，４例再通，再通率６６．６７％；去纤酶组１０例，再通５例，再通率５０．０％。再通表现：梗塞性胸痛明显缓解；抬高ＳＴ段明显下降，平均最大下降率７２．２５±１９．２５％；ＣＫ峰值时间１５．１±３．１小时，ＣＫ一ＭＢ峰值１４．８±２．６小时；再灌注心律改变２１例，占７２．４％。再阻塞９例，占３１．０３％。住院死亡５例，占９．６％。
In this paper, 52 patients with acute myocardial infarction (AMI) within 6 hours of admission to patients with intravenous thrombolytic therapy, the thrombolytic drugs for urokinase (UK), defibrase, of which 6 cases with prostaglandin E1 (PGE1) bolt. The results showed that: 52 cases of recanalization in 29 cases, the recanalization rate of 55.77%. The UK group of 36 cases recanalization in 20 cases, the recanalization rate of 55.56%; UK + PGE1 group of 6 cases, 4 cases of recanalization, the recanalization rate of 66.67%; defibrase group of 10 cases, and then in 5 cases, and then through Rate of 50.0%. Recanalization showed: infarction chest pain was relieved; elevated ST segment decreased significantly, the average maximum rate of decline of 72.25 ± 19.25%; CK peak time of 15.1 ± 3.1 hours, CK MB peak of 14.8 ± 2.6 hours; reperfusion heart rate changes in 21 cases, accounting for 72.4%. Reocclusion in 9 cases, accounting for 31.03%. Inpatient death in 5 cases, accounting for 9.6%.